MAPK genes interact with diet and lifestyle factors to alter risk of breast cancer: The breast cancer health disparities study

Nutrition and Cancer

Volumn 67, Issue 2, 2015, Pages 292-304

  Slattery, Martha L ^a   Lundgreen, Abbie ^a   John, Esther M ^b,c   Torres Mejia, Gabriela ^d   Hines, Lisa ^e   Giuliano, Anna R ^f   Baumgartner, Kathy B ^g   Stern, Mariana C ^h   Wolff, Roger K ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^c STANFORD CANCER INSTITUTE   (United States)

^d INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^e UNIVERSITY OF COLORADO   (United States)

^f H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^g UNIVERSITY OF LOUISVILLE   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; DUAL SPECIFICITY PHOSPHATASE; DUAL SPECIFICITY PHOSPHATASE 4; DUAL SPECIFICITY PHOSPHATASE 6; ESTROGEN RECEPTOR; FOLIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 12; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 9; PROGESTERONE RECEPTOR; STRESS ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG; DUSP4 PROTEIN, HUMAN; FAT INTAKE; MAP3K2 PROTEIN, HUMAN; MAP3K9 PROTEIN, HUMAN; MAPK1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE;

ADULT; AGED; ALCOHOL CONSUMPTION; ALLELE; ANCESTRY GROUP; ARTICLE; BODY MASS; BREAST CANCER; CALCIUM INTAKE; CALORIC INTAKE; CANCER RISK; CONTROLLED STUDY; DIET; DIETARY FIBER; FAT INTAKE; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEALTH DISPARITY; HUMAN; INDIGENOUS PEOPLE; LIFESTYLE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MENOPAUSE; MEXICO; POPULATION BASED CASE CONTROL STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; UNITED STATES; BLOOD; BREAST TUMOR; CASE CONTROL STUDY; EPIDEMIOLOGY; ETHNOLOGY; GENETICS; METABOLISM; MIDDLE AGED; POPULATION GROUP; REGISTER; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; BODY MASS INDEX; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DIET; DIETARY FATS; DIETARY FIBER; DUAL-SPECIFICITY PHOSPHATASES; ENERGY INTAKE; FEMALE; FOLIC ACID; HEALTH STATUS DISPARITIES; HUMANS; LIFE STYLE; MAP KINASE KINASE KINASES; MENOPAUSE; MEXICO; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 14; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE PHOSPHATASES; MITOGEN-ACTIVATED PROTEIN KINASES; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION GROUPS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REGISTRIES; RISK FACTORS; SAN FRANCISCO; SOUTHWESTERN UNITED STATES;

EID: 84924512032     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2015.990568     Document Type: Article

References (58)

1. Imajo M, Tsuchiya Y, and Nishida E: Regulatory mechanisms and functions of MAP kinase signaling pathways. IUBMB Life 58, 312-317, 2006.
2. Qi M and Elion EA: MAP kinase pathways. J Cell Sci 118, 3569-3572, 2005.
3. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, et al.: A central role for JNK in obesity and insulin resistance. Nature 420, 333-336, 2002.
4. Lee YH, Giraud J, Davis RJ, and White MF: c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J Biol Chem 278, 2896-2902, 2003.
5. Kamata H, Honda S, Maeda S, Chang L, Hirata H, et al.: Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120, 649-661, 2005.
6. Lubos E, Kelly NJ, Oldebeken SR, Leopold JA, Zhang YY, et al.: Glutathione peroxidase-1 deficiency augments proinflammatory cytokine-induced redox signaling and human endothelial cell activation. J Biol Chem 286, 35407-35417, 2011.
7. Mulder KM: Role of Ras and Mapks in TGFbeta signaling. Cytokine Growth Factor Rev 11, 23-35, 2000.
8. Nasim MT, Ogo T, Chowdhury HM, Zhao L, Chen CN, et al.: BMPR-II deficiency elicits pro-proliferative and anti-apoptotic responses through the activation of TGFbeta-TAK1-MAPK pathways in PAH. Hum Mol Genet 21, 2548-2558, 2012.
9. To SQ, Knower KC, and Clyne CD: NFkappaB and MAPK signalling pathways mediate TNFalpha-induced Early Growth Response gene transcription leading to aromatase expression. Biochem Biophys Res Commun 433, 96-101, 2013.
10. Burns KA and Vanden Heuvel JP: Modulation of PPAR activity via phosphorylation. Biochim Biophys Acta 1771, 952-960, 2007.
11. Hu R and Kong AN: Activation of MAP kinases, apoptosis and nutrigenomics of gene expression elicited by dietary cancer-prevention compounds. Nutrition 20, 83-88, 2004.
12. Cappellani A, Di Vita M, Zanghi A, Cavallaro A, Piccolo G, et al.: Diet, obesity and breast cancer: an update. Front Biosci (Schol Ed) 4, 90-108, 2012.
13. Lahmann PH, Hoffmann K, Allen N, van Gils CH, Khaw KT, et al.: Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer 111, 762-771, 2004.
14. Morimoto LM, White E, Chen Z, Chlebowski RT, Hays J, et al.: Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control 13, 741-751, 2002.
15. John EM, Phipps AI, and Sangaramoorthy M: Body size, modifying factors, and postmenopausal breast cancer risk in a multiethnic population: the San Francisco Bay Area Breast Cancer Study. Springerplus 2, 239, 2013.
16. Abdel-Maksoud MF, Risendal BC, Slattery ML, Giuliano AR, Baumgartner KB, et al.: Behavioral risk factors and their relationship to tumor characteristics in Hispanic and non-Hispanic white long-term breast cancer survivors. Breast Cancer Research and Treatment 131, 169-176, 2012.
17. Slattery ML, Sweeney C, Edwards S, Herrick J, Baumgartner K, et al.: Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women. Breast Cancer Res Treat 102, 85-101, 2007.
18. Gaudet MM, Gapstur SM, Sun J, Diver WR, Hannan LM, et al.: Active smoking and breast cancer risk: original cohort data and meta-analysis. J Natl Cancer Inst 105, 515-525, 2013.
19. Bjerkaas E, Parajuli R, Weiderpass E, Engeland A, Maskarinec G, et al.: Smoking duration before first childbirth: an emerging risk factor for breast cancer? Results from 302,865 Norwegian women. Cancer Causes Control 24, 1347-1356, 2013.
20. Beasley JM, Coronado GD, Livaudais J, Angeles-Llerenas A, Ortega-Olvera C, et al.: Alcohol and risk of breast cancer in Mexican women. Cancer Causes Control 21, 863-870, 2010.
21. Bowlin SJ, Leske MC, Varma A, Nasca P, Weinstein A, et al.: Breast cancer risk and alcohol consumption: results from a large case-control study. Int J Epidemiol 26, 915-923, 1997.
22. Brooks PJ and Zakhari S: Moderate alcohol consumption and breast cancer in women: from epidemiology to mechanisms and interventions. Alcohol Clin Exp Res 37, 23-30, 2013.
23. Flatt SW, Thomson CA, Gold EB, Natarajan L, Rock CL, et al.: Low to moderate alcohol intake is not associated with increased mortality after breast cancer. Cancer Epidemiol Biomarkers Prev 19, 681-688, 2010.
24. Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE, et al.: Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care 26, 1752-1758, 2003.
25. Redaniel MT, Jeffreys M, May MT, Ben-Shlomo Y, and Martin RM: Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among British women. Cancer Causes Control 23, 1785-1795, 2012.
26. Dalamaga M: Obesity, insulin resistance, adipocytokines and breast cancer: New biomarkers and attractive therapeutic targets. World J Exp Med 3, 34-42, 2013.
27. Eliassen AH, Tworoger SS, Mantzoros CS, Pollak MN, and Hankinson SE: Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women. Cancer Epidemiol Biomarkers Prev 16, 161-164, 2007.
28. Murtaugh MA, Herrick J, Sweeney C, Guiliano A, Baumgartner K, et al.: Macronutrient composition influence on breast cancer risk in Hispanic and non-Hispanic white women: the 4-Corners Breast Cancer Study. Nutr Cancer 63, 185-195, 2011.
29. Slattery ML, John EM, Torres-Mejia G, Lundgreen A, Herrick JS, et al.: Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed population. Carcinogenesis 33, 1512-1521, 2012.
30. John EM, Horn-Ross PL, and Koo J: Lifetime physical activity and breast cancer risk in a multiethnic population: the San Francisco Bay area breast cancer study. Cancer Epidemiol Biomarkers Prev 12, 1143-1152, 2003.
31. John EM, Phipps AI, Davis A, and Koo J: Migration history, acculturation, and breast cancer risk in Hispanic women. Cancer Epidemiol Biomarkers Prev 14, 2905-2913, 2005.
32. Seinost G, Renner W, Brodmann M, Winkler M, Koppel H, et al.: C677T mutation in the methylene tetrahydrofolate reductase gene as a risk factor for venous thrombotic disease in Austrian patients. Thrombosis Research 100, 405-407, 2000.
33. Pradhan SJ, Mishra R, Sharma P, and Kundu GC: Quercetin and sulforaphane in combination suppress the progression of melanoma through the down-regulation of matrix metalloproteinase-9. Experimental and Therapeutic Medicine 1, 915-920, 2010.
34. Slattery ML, John EM, Torres-Mejia G, Lundgreen A, Lewinger JP, et al.: Angiogenesis genes, dietary oxidative balance, and breast cancer risk and progression: The breast cancer health disparities study. Int J Cancer 134, 629-644, 2014.
35. Slattery ML, Caan BJ, Duncan D, Berry TD, Coates A, et al.: A computerized diet history questionnaire for epidemiologic studies. J Am Diet Assoc 94, 761-766, 1994.
36. Murtaugh MA, Sweeney C, Giuliano AR, Herrick JS, Hines L, et al.: Diet patterns and breast cancer risk in Hispanic and non-Hispanic white women: the Four-Corners Breast Cancer Study. Am J Clin Nutr 87, 978-984, 2008.
37. Hernandez-Avila M, Romieu I, Parra S, Hernandez-Avila J, Madrigal H, et al.: Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City. Salud Publica de Mexico 40, 133-140, 1998.
38. Horn-Ross PL, John EM, Lee M, Stewart SL, Koo J, et al.: Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study. Am J Epidemiol 154, 434-441, 2001.
39. Falush D, Stephens M, and Pritchard JK: Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 164, 1567-1587, 2003.
40. Pritchard JK, Stephens M, and Donnelly P: Inference of population structure using multilocus genotype data. Genetics 155, 945-959, 2000.
41. Yu K, Li Q, Bergen AW, Pfeiffer RM, Rosenberg PS, et al.: Pathway analysis by adaptive combination of P-values. Genetic Epidemiology 33, 700-709, 2009.
42. Kai YuOL and William Wheeler: ARTP Gene and Pathway p-values computed using the Adaptive Rank Truncated Product. 0.0 ed. R package. 2011.
43. Li J and Ji L: Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 95, 221-227, 2005.
44. Nyholt DR: A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. American Journal of Human Genetics 74, 765-769, 2004.
45. Rodriguez F, Naderi S, Wang Y, Johnson CE, and Foody JM: High prevalence of metabolic syndrome in young Hispanic women: findings from the national Sister to Sister campaign. Metab Syndr Relat Disord 11, 81-86, 2013.
46. Sentell TL, He G, Gregg EW, and Schillinger D: Racial/ethnic variation in prevalence estimates for United States prediabetes under alternative 2010 American Diabetes Association criteria: 1988-2008. Ethn Dis 22, 451-458, 2012.
47. Romero CX, Romero TE, Shlay JC, Ogden LG, and Dabelea D: Changing trends in the prevalence and disparities of obesity and other cardiovascular disease risk factors in three racial/ethnic groups of USA adults. Adv Prev Med 172423, 2012.
48. Dorow DS, Devereux L, Dietzsch E, and De Kretser T: Identification of a new family of human epithelial protein kinases containing two leucine/ isoleucine-zipper domains. Eur J Biochem 213, 701-710, 1993.
49. Slattery ML, John EM, Torres-Mejia G, Herrick JS, Giuliano AR, et al.: Genetic variation in bone morphogenetic proteins and breast cancer risk in hispanic and non-hispanic white women: The breast cancer health disparities study. International Journal of Cancer/Journal International du Cancer 132, 2928-2939, 2013.
50. Kang Y: Pro-metastasis function of TGFbeta mediated by the Smad pathway. J Cell Biochem 98, 1380-1390, 2006.
51. Lei X, Bandyopadhyay A, Le T, and Sun L: Autocrine TGFbeta supports growth and survival of human breast cancer MDA-MB-231 cells. Oncogene 21, 7514-7523, 2002.
52. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, et al.: Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447, 1087-1093, 2007.
53. Gaudet MM, Kuchenbaecker KB, Vijai J, Klein RJ, Kirchhoff T, et al. Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet 9, e1003173, 2013.
54. Milne RL, Gaudet MM, Spurdle AB, Fasching PA, Couch FJ, et al.: Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined casecontrol study. Breast Cancer Res 12, R110, 2010.
55. Slattery ML, Lundgreen A, and Wolff RK: MAP kinase genes and colon and rectal cancer. Carcinogenesis 33, 2398-2408, 2012.
56. Slattery ML, Lundgreen A, and Wolff RK: Dietary influence on MAPKsignaling pathways and risk of colon and rectal cancer. Nutr Cancer 65, 729-738, 2013.
57. Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, et al.: The landscape of cancer genes and mutational processes in breast cancer. Nature 486, 400-404, 2012.
58. Hori M, Inagawa S, Shimazaki J, Itabashi M, and Hori M: Overexpression of mitogen-activated protein kinase superfamily proteins unrelated to Ras and AF-1 of estrogen receptor alpha mutation in advanced stage human breast cancer. Pathol Res Pract 196, 817-826, 2000.